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Background: The relationship between clinical judgment and indications of the CURB-65 score
in deciding the site-of-care for patients with community-acquired pneumonia (CAP) has not
been fully investigated. The aim of this study was to evaluate reasons for hospitalization of
CAP patients with CURB-65 score of 0 and 1.
Methods: An observational, retrospective study of consecutive CAP patients was performed at
the Fondazione Ca` Granda, Milan, Italy, between January 2005 and December 2006. Themedical
records of hospitalized patients with CAP having a CURB-65 score of 0 and 1 were identified and
reviewed to determine whether there existed a clinical basis to justify hospitalization.
Results: Among the 580 patients included in the study, 218 were classified with a CURB-65 scoreinfarction; ATS, American Thoracic Society; BTS, British Thoracic Society; CAP, community-acquired
e pulmonary disease; CPAP, non-invasive continuous positive airway pressure; CURB-65, confusion,
, blood pressure, and age 65 years; ER, emergency room; FiO2, fraction of inspired oxygen; LOS,
ber; NIV, non-invasive ventilation; PaCO2, partial pressure of carbon dioxide in arterial blood; PaO2,
lood; PSI, pneumonia severity index; SAPS, simplified acute physiology score; SD, standard deviation;
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Hospitalization of CAP patients with low CURB-65 1733of 0 or 1. Among those, 127 were hospitalized, and reasons that justified hospitalization were
found in 104 (83%) patients. Main reasons for hospitalization included the presence of hypoxemia
on admission (35%), failure of outpatient therapy (14%) and the presence of cardiovascular
events on admission (9.7%). Used as the sole indicator for inappropriate hospitalization, the
CURB-65 score had a poor positive predictive value of 52%.
Conclusions: Although the CURB-65 has been proposed as a tool to guide the site of care decision
by international guidelines, this score is not ideal by itself, and should not be regarded as
providing decision support information if a score of 0 and 1 is present. In CAP patients with
CURB-65 scores of 0 or 1, further evaluations should be performed and completed by clinical
judgment.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Community-acquired pneumonia (CAP) is the leading cause
of death from infectious disease in western countries, as
well as a major burden on healthcare resources. The major
impact on the cost of its care is determined by whether or
not a patient is admitted to the hospital.1 Up to 20% of all
patients with CAP are hospitalized in the USA and dollars
spent on these patients account for 90% of the total cost of
care for the disease.2 In view of these considerations,
hospital admission decision represents a cornerstone in the
management of CAP patients and should be based on an
objective assessment of severity of illness, and stratifica-
tion of patients on the basis of their mortality risk.3
In clinical practice, physicians have the availability of
models of prognosis for patients with CAP to quantify
severity of illness and to guide their clinical judgment. One
of most widely accepted and used tools is the CURB-65
score developed by the British Thoracic Society (BTS).4 The
CURB-65 score uses five clinical and laboratory character-
istics (confusion, blood urea nitrogen, respiratory rate,
blood pressure, and age 65 years) and stratifies patients
into three risk groups for mortality: patients with none or
one of these characteristics are considered at low risk for
mortality (0%e2.1%), those with two characteristics at
intermediate risk (9.2%), while those with more than two
characteristics are considered at high risk for mortality (up
to 22%). The CURB-65 score is particularly attractive since it
is easy to remember, simple to compute and, thus, cost-
effective. Two recent systematic reviews and meta-
analysis validated the ability of the CURB-65 in predicting
30-day mortality in patients with CAP.5,6 Moreover, authors
found that CURB-65 performs well at identifying patients
with pneumonia who have a low risk of death.6
Based on its ability in predicting mortality, the CURB-65
has been adopted internationally as a tool in deciding the
site of care for CAP patients, and is now recommended by
a large number of national and international guidelines.3,7,8
Among those, the BTS suggests outpatient management for
patients with a low mortality risk, as well as hospitalization
for patients with intermediate-high mortality risk.8
The relationship between clinical judgment and indica-
tions based on the CURB-65 score in deciding the site-of-
care for patients with CAP has not been yet investigated.
The CURB-65 score could be, thus, used as a quality
improvement tool in order to assess inappropriate hospi-
talizations for CAP patients with low risk for mortality.The aim of this study was to evaluate reasons for hospi-
talization of CAP patients with CURB-65 score of 0 and 1.
Methods
Study design and subjects
This was an observational, retrospective study of consecu-
tive adult patients who were referred to the Emergency
Room (ER) of the IRCCS Fondazione Ca` Granda, Ospedale
Maggiore Policlinico, Milan, Italy, between January 2005
and December 2006 with a diagnosis of CAP. The Institu-
tional Review Board of the hospital approved the study.
Patients  18 years of age and satisfying the criteria for CAP
were included in this study. Immunocompromised patients
were excluded from the study, according to the design of
the CURB-65 score derivation study.4 Among the standard
operating procedures adopted in the study center, neither
the CURB-65 nor the Pneumonia Severity Index (PSI) are
currently used by physicians in the ER for site-of-care
decision that, thus, remains a clinical decision.
Records of all the enrolled patients were reviewed. Data
were collected and included: demographic information,
clinical data on admission to the ER, radiological findings
and laboratory values, microbiological and in-hospital
treatment data, length of stay in the hospital (LOS), in-
hospital mortality. Severity of the pneumonia on admission
was evaluated by the CURB-65 score.4 Missing information
was assumed to be negative or normal when determining
the total score.
Study definitions
CAP was defined as the presence of a new pulmonary
infiltrate seen on chest radiograph or computed tomog-
raphy scan of the chest within 48 h after hospitalization
with at least one of the following: 1) new or increased
cough with/without sputum production; 2) fever (docu-
mented temperature -rectal or oral-  38.3 or <36 C); 3)
evidence of systemic inflammation (such as abnormal white
blood cell count -either leukocytosis, >10,000/cm3, or
leucopenia, < 4000/cm3- or C-reactive protein or pro-
calcitonin values above the local upper limit). LOS was
calculated as the number of days from the date of admis-
sion to the date of discharge. Immunodepression was
considered in patients with neoplastic disease (defined as
1734 S. Aliberti et al.any type of malignancy that was diagnosed in the previous
12 months or as active cancer), human immunodeficiency
virus infection, autoimmune diseases, transplantation, and
those undertaking immunosuppressive drugs and steroids.
In-hospital mortality was defined as death by any cause
during hospitalization. Patients were followed from day of
admission to day 28; those who remained hospitalized for
more than 28 days were considered alive. Any patient who
was diagnosed and treated in the Emergency Room for less
than 24 h before being discharged was regarded as dis-
charged from the hospital.
Study groups
The CURB-65 score was calculated for every patient who
referred to the ER during the study period. Among patients
with a CURB-65 score of 0 or 1 on admission to the ER two
groups of patients were identified: those who were hospi-
talized, Group 1, and those sent home, Group 2.
Analysis of the reasons for admission
Patients in Group 1 were identified as being potentially
inappropriate for hospitalization. Each case record was
submitted to the clinical judgment of a review committee
of one infectious diseases, one internist and three pulmo-
nary specialists. None of the reviewers was involved in the
initial care of the patients and they were also blinded to
patient outcomes. After discussion, the committee deter-
mined whether there was any clinical basis for hospital
admission. If no clinical basis was determined, the hospital
admission was deemed to be inappropriate. If there was
a clinical basis for hospital admission of patients in Group 1,
the reasons for hospitalization were classified as: (1) new or
decompensated medical conditions other than CAP; (2)
hypoxemia; (3) failure of outpatient therapy; (4) oral
intolerance; (5) suspicion of sepsis; (6) bilateral pneumonia
or pleural fluid drainage; (7) unmet social needs; (8) need
of further work-up.
The category new or decompensated medical conditions
other than CAP that required hospitalization included
patients admitted to the hospital for treatment of
a concomitant medical condition, new or decompensated.
Among those, we identified cardiovascular events (i.e.
acute myocardial infarction, acute decompensated heart
failure, new arrhythmia or acute worsening of a long-term
arrhythmia), neurological events (i.e. transient ischemic
attack, cerebrovascular accidents seizure), exacerbations
of chronic obstructive pulmonary disease (COPD) and
exacerbations of asthma. Hypoxemia was defined as arte-
rial oxygen saturation <90% or a PaO2 value <60 mmHg or
a PaO2/FiO2 ratio value < 300) or clinical evidence of acute
respiratory failure, such as respiratory distress. Failure of
outpatient therapy was understood as meaning the patient
was having persistent symptoms despite receiving appro-
priate oral antimicrobial treatment at home, consistent
with the latest American Thoracic Society (ATS) guidelines.3
Oral intolerance was defined as inability of the patient in
gastrointestinal absorption of oral antibiotic therapy.
Suspicion of severe sepsis was considered when the primary
physician included sepsis in the differential diagnosis of thepatient on hospital admission and a suspicion of severe
sepsis was considered to be appropriate by the review
committee. Unmet social needs included any non-medical
reason that prevented adequate outpatient treatment of
CAP (i.e, homelessness). Need of further work-up was
described when urgent tests were performed in order to
reach a diagnosis, such as the need to role out tuberculosis
in the presence of haemoptysis. A consensus was reached
with each case presented to the review committee. In cases
where unanimous consensus was not reached, a majority
decision was employed.
Statistical analysis
All data were statistically analyzed with SPSS (version 14.0,
Chicago, Il). Descriptive statistics were reported at baseline
with continuous data expressed as a mean  SD and cate-
gorical data expressed as counts. Summary statistics for all
continuous explanatory variables were presented as means
with differences between groups compared by means of
independent t-tests. Categorical explanatory variables
were summarized as percentages with differences between
groups analyzed using the chi-square test or the Fisher
exact test were appropriate. The positive predictive value
of the CURB-65 as an indicator of inappropriate hospitali-
zation was determined by calculating the proportion of
patients with CURB-65 score 0 and 1 in whom we were
unable to find any justification for hospitalization, out of
the total number of inpatients with a score 0 and 1, that is,
by dividing the number of outpatients or unjustified
patients who had been admitted to the hospital by the total
number of patients with score 0 and 1.
Results
A total of 714 patients were enrolled during the study
period, and among them 134 were excluded from the
analysis due to the presence of immunosuppression. The
final study population was composed of 580 patients.
Demographics, comorbidities, severity of disease on
admission, radiological, physical and laboratory findings on
admission of the study population are summarized in Table
1. The flow chart of the study population is depicted in
Fig. 1, according to the CURB-65 score, as well as the final
site of care.
A total of 218 patients were classified with a CURB-65
score of 0 or 1 on admission to the ER, and among them 127
(58%) were hospitalized (Group 1), while 91 were sent home
(Group 2). Demographics, comorbidities, severity of disease
on admission, radiological, physical and laboratory findings
on admission, microbiology data and outcomes of patients
with CURB-65 score of 0 and 1 are summarized in Table 2,
according to final the site of care decision. Patients in
Group 1 were older, with a higher prevalence of chronic
cardiovascular and pulmonary diseases, and more severe
presentation on admission. More than one-third needed
oxygen therapy in the ER, while almost 8% needed either
continuous positive airway pressure or non-invasive
mechanical ventilation on admission.
A consensus among the reviewers was achieved in 100%
of cases for assigning reasons for hospitalization, with an
Table 1 Demographics, comorbidities, severity, radiological, physical and laboratory findings on admission of the study
population.
Characteristic Study population n Z 580
Demographics
Male, n (%) 322 (56)
Age, mean  SD years 68  20
Current tobacco smoker, n (%) 68 (12)
Comorbidities
Cardiovascular disease, n (%) 295 (51)
Chronic obstructive pulmonary disease, n (%) 148 (26)
Diabetes mellitus, n (%) 82 (14)
Chronic renal insufficiency, n (%) 42 (7.2)
Neurological diseases, n (%) 149 (26)
Asthma, n (%) 13 (2.2)
Severity on admission
Oxygen therapy, n (%) 256 (44)
NIV and/or CPAP use, n (%) 73 (13)
Radiological findings
Bilateral pneumonia, n (%) 62 (11)
Pleural effusion, n (%) 119 (21)
Physical findings
Temperature, mean  SDC 37.4  1.2
Systolic Blood Pressure, mean  SD mmHg 133  25
Diastolic Blood Pressure, mean  SD mmHg 75  15
Heart rate, mean  SD beats/minute 97  21
Respiratory Rate, mean  SD breath/minute 25  10
Arterial Oxygen Saturation, mean  SD (%) 92  7
Laboratory values
Arterial pH, mean  SD 7.43  0.08
PaCO2, mean  SD mmHg 38  12
PaO2/FiO2 ratio, mean  SD 275  81
White Blood Cell, mean  SD cell/L1 12.5  6.8
Creatinine, mean  SD mg/dL 1.5  1
Urea, mean  SD mg/dL 61  47
Empiric antibiotic therapy
Azithromycin, n. (%) 290 (50)
Ceftriaxone, n. (%) 208 (36)
Levofloxacin, n. (%) 119 (21)
Piperacillin/tazobactam, n. (%) 55 (9.5)
Imipenem, n. (%) 25 (4.3)
Monotheray, n. (%) 51 (8.8)
Microbiology
S. pneumoniae, n. (%) 36 (6.2)
S. aureus, n. (%)a 17 (2.9)
L. pneumoniae, n. (%) 15 (2.6)
M. pneumoniae, n. (%) 9 (1.6)
P. aeruginosa, n. (%) 8 (1.4)
Enterococcus, n. (%) 8 (1.4)
C. pneumoniae, n. (%) 6 (1.3)
Other 11 (1.9)
PaO2: partial pressure of oxygen in arterial blood; PaCO2: partial pressure of carbon dioxide in arterial blood; FiO2 fraction of inspired
oxygen; SD Standard deviation; n: number; SAPS: simplified acute physiology score; NIV: non-invasive ventilation; CPAP: non-invasive
continuous positive airway pressure.
a 7 methicillin-resistant S. aureus.
Hospitalization of CAP patients with low CURB-65 1735unanimous decision in 95% of the cases. Among the 127
patients belonging to Group 1, reasons that justified
hospitalization were found in 104 (83%) patients, see Table
3. No clinical justification for hospitalization was identifiedin 23 patients (17%). The calculated positive predictive
value of the CURB-65 score as a sole indicator for inap-
propriate hospitalization was 52%. Among those in Group 1,
one patient died.
Figure 1 Flow chart of the study population according to the
CURB-65 score risk classes and the final site of care (IN:
hospitalized; OUT: sent home).
1736 S. Aliberti et al.A total of 362 patients were classified with a CURB-65
score of 2-to-5 on admission to the ER, and among them 360
(99%) were hospitalized, while 2 were sent home. Among
patients with CURB-65 score of 2-to-5 who were hospital-
ized, 54 (15%) patients died.
Discussion
The main findings of the present study are: 1) among
patients presenting in the Emergency Room with a CURB-65
score of 0 or 1, almost 50% are appropriately hospitalized
based on clinical judgment; 2) main reasons for hospitali-
zation of patients with CURB-65 of 0 and 1 include the
presence of hypoxemia on admission, failure of outpatient
therapy and the presence of cardiovascular events on
admission; 3) used as the sole indicator for inappropriate
hospitalization, the CURB-65 score had a poor positive
predictive value of 52%.
A major concern exists in literature whether the
prediction of death performed by the CURB-65 score could
also be an appropriate criterion for hospitalization, in viewTable 2 Findings on admission of patients with CURB-65 score
Characteristic Grou
Demographics
Male, n. (%) 69 (5
Age, mean  SD years 58 
Current tobacco smoker, n. (%) 17 (1
Comorbidities
Cardiovascular disease, n. (%) 41 (3
Chronic obstructive pulmonary disease, n. (%) 30 (2
Diabetes mellitus, n. (%) 12 (1
Neurological diseases, n. (%) 14 (1
Severity on admission
Oxygen therapy, n. (%) 46 (3
NIV/CPAP use, n. (%) 10 (7
Physical findings
Systolic Blood Pressure, mean  SD mmHg 135
Diastolic Blood Pressure, mean  SD mmHg 78 
Heart rate, mean  SD beats/minute 97 
Respiratory Rate, mean  SD breath/minute 21 
Arterial Oxygen Saturation, mean  SD (%) 95 
Group 1: patients who were hospitalized; Group 2: patients who were
ventilation; CPAP: non-invasive continuous positive airway pressure.of the fact that the CURB-65 score was not initially devel-
oped to choose the site of care for CAP patients. Based on
the CURB-65 ability in predicting mortality, guidelines have
suggested its use to decide the site-of-care. However, some
data showed discrepancy between the CURB-65 score and
clinical judgment, as well as a misleading performance of
this score in young adults.9
We found that the site-of-care decision based on the
CURB-65 score was inconsistent with clinical judgment in
one out of five CAP patients presenting at the ER. In almost
the total of the cases, the discrepancy involved hospitali-
zation of CAP patients with a score of 0 and 1 due to the
presence of hypoxemia on admission, failure of outpatients
therapy and decompensated medical conditions. Our data
are consistent with those recently published by Choudhury
and coworkers who identified reasons justifying hospitali-
zation in 83% of patients with CURB-65 score of 0 and 1 who
were admitted to the hospital.10 Similarly to our results,
these authors found hypoxemia and decompensated
comorbidities playing a major role in this decision.
The CURB-65 score suffers of a lack a formal assessment
of hypoxemia, a major drawback in light of the importance
of assessing oxygenation immediately on arrival at the ER.
We found that hypoxemia was a reason for hospitalization
in almost one-third of CAP patients with CURB-65 score of
0 and 1. Our data are consistent with a recent prospective,
multicenter study by Sanz and coworkers who identified
hypoxemia at the time of admission in almost 50% of
patients with CURB-65 score of 0-1.11 The authors found
that these patients had a prolonged length of hospital stay,
higher rate of admissions in the intensive care unit and
development of severe sepsis as well as mortality in
comparison to non-hypoxemic patients. Our data are also
consistent with findings reported by Ronan et al. who
identified bilateral/multilobar appearance of the chestof 0 and 1.
p 1 n Z 127 Group 2 n Z 91 p
4) 48 (53) 0.885
19 41  16 <0.001
3) 0 (0) <0.001
2) 10 (11) 0.001
4) 2 (2.2) <0.001
0) 2 (2.2) 0.036
1) 5 (5.6) 0.155
6) 0 <0.001
.9) 0 0.006
 20 127  16 0.005
12 74  11 0.020
21 97  19 0.977
7 15  4 <0.001
4 97  2 <0.001
sent home; SD Standard deviation; n: number; NIV: non-invasive
Table 3 Reasons that justified hospitalization among patients with a CURB-65 score of 0 or 1.
Reasons N. (%)
1. Hypoxemia 36 (35)
2. Failure of outpatient therapy 15 (14)
3. Cardiovascular events 10 (9.7)
4. Further Work-up 8 (7.8)
5. Neurological events 7 (6.7)
6. Exacerbation of COPD 6 (5.8)
7. Exacerbation of asthma 4 (3.8)
8. Bilateral pneumonia 3 (2.9)
9. Unmet social needs 3 (2.9)
11. Severe hemoptysis 1 (0.9)
12. Suspicion of severe sepsis 1 (0.9)
13. Oral intolerance 1 (0.9)
14. Others 9 (8.7)
N: number; COPD: chronic obstructive pulmonary disease.
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with CURB-65 score of 0-2.12 The lack of evaluation by the
CURB-65 score of hypoxemia on admission is important in
view of the fact that current guidelines clearly consider
hypoxemia as an absolute contraindication to outpatient
treatment of CAP.13
We found that failure of outpatient therapy was one of
themain reasons for hospitalization in patientswith CURB-65
score of 0 and 1. The majority of the panel agreed to
hospitalize these patients in order to increase spectrum of
pathogen coverage with endovenous antibiotics. This deci-
sion is in accordance with the latest guidelines published by
the ATS in 2007 indicating failure of outpatient therapy as
clinical indication for more extensive diagnostic testing.
There are some concerns in clinical practice that the
CURB-65 scoremaynotbe easily applied in older patientswho
may still have substantialmortality risk, even if amild formof
CAP destabilizes a chronic, but compensated, disease
process. Our findings confirmed this hypothesis with the
identification of the concomitant presence of CAP and other
decompensated comorbidities that influenced the admission
decision in 32% of the patients. Among the decompensated
comorbidities, we mainly identified cardiovascular and
neurological events, as well as exacerbations of chronic
obstructive pulmonary disease. The impact of cardiovascular
events in CAP patients has been recently analyzed by
different groups of investigators. Perry et al. used data from
administrative databases of the Department of Veterans
Affairs in the USA and found that hospitalization for pneu-
monia is associated with a clinically significant number of
cardiovascular events and that the majority of these events
occur during the initial hospitalization.14 The incidence of
acute myocardial infarction (AMI) at the time of hospital
admission in patients with CAP has been shown to be up to 7%
in different settings.15,16 Moreover, we recently identified
AMI to bealso oneof themain causes for clinical failure during
hospitalization for patients with CAP.17
When we analyzed clinical judgment versus the CURB-65
score 2-to-5, we found an almost complete concordance in
the decision of the site of care for CAP patients. We can
speculate that the presence of at least two out of fivecriteria of the CURB-65 is able to recognize those patients
who could need hospitalization.
Our study has different limitations. In view of the
retrospective design of the study, we did not have enough
data to perform a full analysis of patients who were dis-
charged from the ER. Furthermore, missing information
regarding the use of vasopressors as well as respiratory rate
values on admission was present and we assumed the
patient had normal respiratory rate if otherwise reported in
the ER charts. Furthermore, we were not able to identify
patients with healthcare associated pneumonia, in order to
evaluate the CURB-65 score in the site-of-care decision for
these group of patients.
Our study is strengthened by the evaluation of
a consecutive population of patients with CAP in a teaching
hospital. Likewise, another strength is the incorporation of
a multidisciplinary review committee that judged the
appropriateness of hospitalization for every case by
consensus. Similar clinical consensus methods have been
previously used in studying the etiology of mortality in
cancer, cardiovascular disease and pneumonia.17
Our findings have different implications. From a clinical
point of view, as suggested by the BTS guidelines, the
CURB-65 should be strongly supported by clinical judgment
in order to decide the site of care for CAP patients, espe-
cially if a score of 0 or 1 is present. In this case, an accurate
evaluation of the presence of acute respiratory failure as
well as other decompensated comorbidities is needed.
From a research point of view, since the CURB-65 is not
a good tool in deciding the site-of-care in CAP patients with
score 0 and 1, further research is needed to improve the
predictability of CURB-65 in low score patients. Further-
more, a comparison between the CURB-65 score and the PSI
is also needed in order to evaluate the concordance of the
two scoring systems in deciding the site of care for patients
with CAP. Findings from the present study could be useful in
modifying the CURB-65 score in order to maintain its
simplicity and improve site-of-care ability.
Although the CURB-65 has been proposed as a tool to
guide the site of care decision by international guidelines,
this score is not ideal by itself, and should not be regarded
1738 S. Aliberti et al.as providing decision support information if a score of 0 and
1 is present. In CAP patients with CURB-65 scores of 0 or 1,
further evaluation of the presence of hypoxemia, as well as
decompensated comorbidities should be performed and
completed by clinical judgment.
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